{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-030190","form_type":"8-K","ticker":"VVOS","cik":"0001716166","company_name":"Vivos Therapeutics, Inc.","filed_at":"2026-06-25T21:22:26+00:00","discovered_at":"2026-06-25T21:24:00.305616+00:00","generated_at":"2026-06-25T21:24:24.390388+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Vivos extends debt-to-equity conversion deadline with Streeterville to Aug 31, 2026","bullets":["Streeterville extends timeframe for converting up to $4.5M debt into perpetual preferred and common stock to August 31, 2026.","Conversion is contingent on Vivos raising at least $2.6M in equity; occurs dollar-for-dollar up to $4.5M.","Extension allows Vivos to conduct planned rights offering and maintain Nasdaq listing compliance.","Original June 5, 2026 agreement had June 15 deadline; Company needed more time to complete equity raise.","CEO Kirk Huntsman expresses gratitude for Streeterville's cooperation and support on new strategic business model."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-030190","json":"https://secwatch.observer/filing/0001493152-26-030190.json","markdown":"https://secwatch.observer/filing/0001493152-26-030190.md","text":"https://secwatch.observer/filing/0001493152-26-030190.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716166/000149315226030190/0001493152-26-030190-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716166/000149315226030190/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T21:24:24.390388+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}